The US Medical Aesthetics Market was valued at $7644.5 Million in 2025 and projected to reach to $16700.8 Million by 2031, representing a compound annual growth rate of 13.9%. The US medical aesthetics market is positioned for sustained growth through 2031, driven by evolving consumer preferences toward non-surgical beauty enhancement and increasing accessibility of treatments.
The US medical aesthetics market is valued at $7,644.5 million in 2025 and is projected to reach $16,700.8 million by 2031, representing a robust 13.9% CAGR over the forecast period.
US consumers are increasingly opting for minimally invasive aesthetic procedures due to shorter recovery times, reduced risks, and growing social acceptance of cosmetic treatments across all demographics.
Growing disposable incomes in the US are enabling more consumers to invest in aesthetic treatments, expanding the addressable market beyond traditional high-income segments to middle-class demographics.
Advanced laser systems, injectable formulations, and body contouring technologies are being rapidly adopted in the US market, driving procedure efficacy and patient satisfaction rates.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | HOME CARE SETTINGS (End User) |
| Forecast Period | 2025–2039 |
| Growth Rate | CAGR of 13% from 2025 to 2039 |
| Largest Segment | DERMATOLOGY CLINICS, HOSPITALS, AND MEDICAL SPAS (End User) |
| Market Size Base Year (Billions) | ~USD 19.55 (2025) |
| Revenue Forecast (Billions) | ~USD 40.7 (2039) |
| Segments Covered | Product, Type, Product Type, Procedure, End User |
5 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ALLERGAN PLC | Ireland | Private Company | Botox,Filler,Liposuction, |
| SIENTRA, INC. | United States | Private Company | Silicone Gel Breast Implants,Body Contouring Products,Scar Management Products, |
| ABBVIE INC. | United States | Public Company | Botox Cosmetic,Juvederm Collection,Body Contouring, |
| GALDERMA | Switzerland | Public Company | Dermal Fillers,Botox,Laser Resurfacing, |
| JOHNSON & JOHNSON | United States | Public Company | Fillers,Laser Resurfacing,Botox, |
| BAUSCH HEALTH COMPANIES INC. | Canada | Public Company | Laser Resurfacing,RF,Fillers, |
| CUTERA, INC. | United States | Private Company | Laser Resurfacing,RF Microneedling,Hair Removal, |
| LUMENIS BE LTD. | Israel | Private Company | Laser Hair Removal,Skin Treatment,RF and Phototherapy, |
| CANDELA MEDICAL | United States | Private Company | Laser Resurfacing,Hair Removal,RF and Phototherapy, |
| INMODE LTD. | Israel | Public Company | RF Technology,Laser Resurfacing,Hair Removal, |
Allergan PLC is an Irish private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and medical aesthetics sectors.
Sientra, Inc. is a United States-based private company founded in 2003 with 304 employees. The company focuses on medical device manufacturing and aesthetics.
AbbVie Inc. is a publicly traded United States company founded in 2012 with 57,000 employees. The company operates as a global pharmaceutical and healthcare company.
Galderma is a Swiss public company founded in 1981 with 7,676 employees. The company specializes in dermatology and aesthetic medicine products.
Johnson & Johnson is a publicly traded United States company founded in 1886 with 138,200 employees. The company is a diversified healthcare conglomerate operating in pharmaceuticals, medical devices, and consumer health.
Bausch Health Companies Inc. is a Canadian public company with 20,300 employees. The company operates across pharmaceuticals, medical devices, and eye care sectors.
Cutera, Inc. is a United States-based private company founded in 1998 with 430 employees. The company develops and manufactures laser and light source-based aesthetic systems.
Lumenis Be Ltd. is an Israeli private company founded in 1991 with 954 employees. The company specializes in laser and light-based medical and aesthetic devices.
Candela Medical is a United States-based private company founded in 1970 with 363 employees. The company manufactures laser and light-based medical aesthetic devices.
InMode Ltd. is an Israeli public company founded in 2008 with 660 employees. The company develops and markets minimally invasive aesthetic medical devices.
The US medical aesthetics market is valued at $7,644.5 million in 2025, with expectations to grow significantly through 2031.
The US medical aesthetics market is projected to reach $16,700.8 million by 2031, representing more than a doubling of market value.
The US medical aesthetics market is expected to grow at a compound annual growth rate (CAGR) of 13.9% from 2025 to 2031.
Key growth drivers in the US include increasing consumer demand for minimally invasive procedures, rising disposable incomes, technological advancements, and growing social acceptance of aesthetic treatments.
The US market is led by botulinum toxin, dermal fillers, laser resurfacing, and radiofrequency therapies, with continuous innovation expanding treatment options.
Four primary studies have been undertaken to size the medical aesthetics market. Secondary research has been used to obtain preliminary data for the medical aesthetics market and peer and parent markets. Data were collected from 3–5 secondary sources and validated by primary sources for assumptions and market sizing. Through top-down and bottom-up approaches, the overall market size was informed and further broken down, and data was triangulated for segment and subsegment sizing.
Secondary research included directories, Factiva, white papers, Bloomberg Businessweek, annual reports, SEC filings, business filings, and investor presentations, among others. Through these sources, one can gain critical data about market leaders, how the industry is divided into sectors, and how technology varies from one industry level to another within medical aesthetics.
Primary research included interviewing people from the supply side of the business and the demand side to get quantitative and qualitative insights. On the demand side, primary sources involved in the study included physicians, researchers, department heads, staff from diagnostic centers, hospital staff, and those attached to the research institutes. On the supply side, these sources involved CEOs, area sales managers, territory and regional sales managers, and various other top executives of relevant companies. These direct meetings with people in key leadership positions helped validate assumptions arising from secondary research and bring them face-to-face so that any assumptions could also be directly questioned.
A breakdown of the primary respondents is provided below:

Notes:
*Others include Sales Managers, Marketing Managers, Business Development Managers, Product Managers, Distributors, and Suppliers.
Companies are classified into tiers based on their total revenue. As of 2025, the following tiers have been used:
Tier 1 = > USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million
To know about the assumptions considered for the study, download the pdf brochure
The revenue share analysis of major companies was used in this report to determine the size of the global medical aesthetics market. This was accomplished by identifying the major market participants and calculating their medical aesthetics business revenues using a variety of information acquired throughout the primary and secondary research stages. Examining the annual and financial reports of the leading market participants was one aspect of secondary research. On the other hand, primary research involved in-depth interviews with important thought leaders, including directors, CEOs, and important marketing executives. Segmental revenues were computed using the revenue mapping of the leading solution/service providers to determine the worldwide market value.
The following steps were involved in this process:

After determining the overall market size through the process of estimation as discussed above, the global medical aesthetics market has been segmented and subsegmented. Data triangulation and market breakdown methods have been used to refine the accuracy of these estimates. This process is based on the analysis of multiple factors and trends from the demand and supply perspectives. The medical aesthetics market has been validated through the top-down and bottom-up approaches, ensuring the accuracy of the segment and subsegment statistics.
The medical aesthetics market comprises products and procedures designed to enhance aesthetic appearance through non-surgical or surgical interventions targeting facial, skin, body, hair, and nail cosmetic concerns. The market includes facial aesthetic products, body contouring devices, cosmetic implants, skin aesthetic devices, physician-dispensed eyelash products, hair removal devices, tattoo removal devices, thread lift products, nail treatment laser devices, and home care aesthetic devices. The market serves end users, including clinics, hospitals, medical spas, beauty centers, and home care settings.
Product Analysis
Full forecast, segment splits, and company analysis for all Medical Aesthetics Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report